Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Per-Uno Malmström. (2020) Cystoscopic surveillance of patients with non-muscle-invasive bladder cancer revisited. Scandinavian Journal of Urology 54:5, pages 364-366.
Read now
Read now
Anastasios Anastasiadis, Ernesto Cordeiro, Mieke TJ Bus, Gerasimos Alivizatos, Jean JMCH de la Rosette & Theo M de Reijke. (2012) Follow-up procedures for non-muscle-invasive bladder cancer: an update. Expert Review of Anticancer Therapy 12:9, pages 1229-1241.
Read now
Read now
Lars Lund, R Erichsen, M Nørgaard, E H Larsen, M Borre & J Jacobsen. (2011) Survival of invasive bladder cancer patients, 1998–2009; a central and northern Denmark population-based cohort study. Clinical Epidemiology 3:sup1, pages 47-51.
Read now
Read now
Charlotta Ryk, N. Peter Wiklund, Tommy Nyberg & Petra J. De Verdier. (2011) Ser608Leu polymorphisms in the nitric oxide synthase-2 gene may influence urinary bladder cancer pathogenesis. Scandinavian Journal of Urology and Nephrology 45:5, pages 319-325.
Read now
Read now
Andreas Thorstenson, Martin C. Schumacher, N. Peter Wiklund, Martin N. Jonsson, Per Larsson, Hans Wijkström, Erik Onelöv, Gunnar Steineck & Petra J. De Verdier. (2010) Diagnostic random bladder biopsies: Reflections from a population-based cohort of 538 patients. Scandinavian Journal of Urology and Nephrology 44:1, pages 11-19.
Read now
Read now
Alan R. Schned, Angeline S. Andrew, Carmen J. Marsit, Karl T. Kelsey, Michael S. Zens & Margaret R. Karagas. (2008) Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scandinavian Journal of Urology and Nephrology 42:3, pages 237-242.
Read now
Read now
Somali Sanyal, Petra J. De Verdier, Gunnar Steineck, Per Larsson, Erik Onelöv, Kari Hemminki & Rajiv Kumar. (2007) Polymorphisms in XPD, XPC and the risk of death in patients with urinary bladder neoplasms. Acta Oncologica 46:1, pages 31-41.
Read now
Read now
Somali Sanyal, Charlotta Ryk, Petra J. De Verdier, Gunnar Steineck, Per Larsson, Erik Onelöv, Kari Hemminki & Rajiv Kumar. (2007) Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms. Scandinavian Journal of Urology and Nephrology 41:3, pages 182-190.
Read now
Read now
Cheng‐Chuan Su, Chee‐Wai Mak & Steven K. Huan. (2007) Diagnosis of primary ureteral small cell carcinoma in instrumented urine cytology. Pathology 39:3, pages 365-367.
Read now
Read now
Petra J. Berggren De Verdier, Rajiv Kumar, Jan Adolfsson, Per Larsson, Ulf Norming, Erik Onelöv, Hans Wijkström, Gunnar Steineck & Kari Hemminki. (2006) Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16)/ARF (p14) locus in urinary bladder cancer. Scandinavian Journal of Urology and Nephrology 40:5, pages 363-369.
Read now
Read now
Karin Falkman, Bernhard Tribukait, Claes R. Nyman, Per Larsson & Ulf Norming. (2004) S‐phase fraction in superficial urothelial carcinoma of the bladderA prospective, long‐term, follow‐up study. Scandinavian Journal of Urology and Nephrology 38:4, pages 278-284.
Read now
Read now
Articles from other publishers (54)
Andrii Puzyrenko, Laila Nomani, Kenneth Iczkowski & Tamara Giorgadze. (2022) Small cell carcinoma of the urinary bladder: Distinctive cytological characteristics and Cyto-histologic correlation. Annals of Diagnostic Pathology 59, pages 151947.
Crossref
Crossref
Zachary Dovey, John Pfail, Alberto Martini, Gunnar Steineck, Linda Dey, Lotta Renström, Abolfazl Hosseini, John P. Sfakianos & Peter Wiklund. (2022) Bladder Cancer (NMIBC) in a population-based cohort from Stockholm County with long-term follow-up; A comparative analysis of prediction models for recurrence and progression, including external validation of the updated 2021 E.A.U. model. Urologic Oncology: Seminars and Original Investigations 40:3, pages 106.e1-106.e10.
Crossref
Crossref
Haoyue Sheng, Guiming Zhang, Yongqiang Huang, Lijiang Sun, Guohai Shi & Dingwei Ye. (2021) A 5-lncRNA Signature Associated with Smoking Predicts the Overall Survival of Patients with Muscle-Invasive Bladder Cancer. Disease Markers 2021, pages 1-10.
Crossref
Crossref
Meltem ÖZNUR, Murat AKGÜL, Ayşegül İSAL ARSLAN, Cenk Murat YAZICI & Enes ALTIN. (2020) YÜKSEK DERECELİ KASA İNVAZE OLMAYAN MESANE TÜMÖRLERİNDE HİSTOLOJİK DERECELENDİRME ORANININ PROGRESYONA ETKİSİ. Namık Kemal Tıp Dergisi.
Crossref
Crossref
Ning Jiang, Dawei Tian, Zhonghua Shen, Peikang Wu, Yuwei Hou, Linguo Xie, Yuzhu Li, Xiang Zhang, Xiaogang Tang, Hailong Hu, Qiong Pei & Changli Wu. (2020) Small cell carcinoma of the upper urinary tract and factors associated with progress survival: a systematic review and pooled analysis. Minerva Urologica e Nefrologica 72:2.
Crossref
Crossref
Alberto Martini, John P. Sfakianos, Lotta Renström‐Koskela, Ashkan Mortezavi, Ugo G. Falagario, Lars Egevad, Abolfazal Hosseini, Reza Mehrazin, Matthew D. Galsky, Gunnar Steineck & N. Peter Wiklund. (2019) The natural history of untreated muscle‐invasive bladder cancer. BJU International 125:2, pages 270-275.
Crossref
Crossref
Vebjørn Kvikstad, Ok Målfrid Mangrud, Einar Gudlaugsson, Ingvild Dalen, Hans Espeland, Jan P. A. Baak & Emiel A. M. Janssen. (2019) Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas. Diagnostic Pathology 14:1.
Crossref
Crossref
Tomas Thiel, Charlotta Ryk, Lotta Renström-Koskela, Gunnar Steineck, Martin C. Schumacher, N. Peter Wiklund & Petra J. de Verdier. (2018) Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer. World Journal of Urology 37:1, pages 155-163.
Crossref
Crossref
A. N. Srivastava, Kirti A. Gautam & S. N. Sankhwar. 2019. Molecular Diagnostics in Cancer Patients. Molecular Diagnostics in Cancer Patients
219
235
.
Hui Wang, Weihong Ding, Guangliang Jiang, Yuancheng Gou, Chuanyu Sun, Zhongqing Chen, Ke Xu & Guowei Xia. (2018) EORTC risk tables are more suitable for Chinese patients with nonmuscle-invasive bladder cancer than AUA risk stratification. Medicine 97:36, pages e12006.
Crossref
Crossref
Andreas Thorstenson. (2017) Urothelial Carcinoma of the Bladder in Swedish Geriatric Patients: A Population-based Study. MOJ Gerontology & Geriatrics 1:3.
Crossref
Crossref
Charlotta Ryk, Lotta Renström Koskela, Tomas Thiel, N. Peter Wiklund, Gunnar Steineck, Martin C. Schumacher & Petra J. de Verdier. (2015) Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes. Redox Biology 6, pages 272-277.
Crossref
Crossref
Ismail Hosen, P. Sivaramakrishna Rachakonda, Barbara Heidenreich, Petra J. de Verdier, Charlotta Ryk, Gunnar Steineck, Kari Hemminki & Rajiv Kumar. (2015)
Mutations in
TERT
promoter and
FGFR3
and telomere length in bladder cancer
. International Journal of Cancer 137:7, pages 1621-1629.
Crossref
Crossref
Thorunn Rafnar, Patrick Sulem, Gudmar Thorleifsson, Sita H. Vermeulen, Hannes Helgason, Jona Saemundsdottir, Sigurjon A. Gudjonsson, Asgeir Sigurdsson, Simon N. Stacey, Julius Gudmundsson, Hrefna Johannsdottir, Kristin Alexiusdottir, Vigdis Petursdottir, Sigfus Nikulasson, Gudmundur Geirsson, Thorvaldur Jonsson, Katja K.H. Aben, Anne J. Grotenhuis, Gerald W. Verhaegh, Aleksandra M. Dudek, J. Alfred Witjes, Antoine G. van der Heijden, Alina Vrieling, Tessel E. Galesloot, Ana De Juan, Angeles Panadero, Fernando Rivera, Carolyn Hurst, D. Timothy Bishop, Sei C. Sak, Ananya Choudhury, Mark T.W. Teo, Cecilia Arici, Angela Carta, Elena Toninelli, Petra de Verdier, Peter Rudnai, Eugene Gurzau, Kvetoslava Koppova, Kirstin A. van der Keur, Irene Lurkin, Mieke Goossens, Eliane Kellen, Simonetta Guarrera, Alessia Russo, Rossana Critelli, Carlotta Sacerdote, Paolo Vineis, Clémentine Krucker, Maurice P. Zeegers, Holger Gerullis, Daniel Ovsiannikov, Frank Volkert, Jan G. Hengstler, Silvia Selinski, Olafur T. Magnusson, Gisli Masson, Augustine Kong, Daniel Gudbjartsson, Annika Lindblom, Ellen Zwarthoff, Stefano Porru, Klaus Golka, Frank Buntinx, Giuseppe Matullo, Rajiv Kumar, José I. Mayordomo, D. Gunnar Steineck, Anne E. Kiltie, Eirikur Jonsson, François Radvanyi, Margaret A. Knowles, Unnur Thorsteinsdottir, Lambertus A. Kiemeney & Kari Stefansson. (2014) Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer. Human Molecular Genetics 23:20, pages 5545-5557.
Crossref
Crossref
Ashish M. Kamat, J. Alfred Witjes, Maurizio Brausi, Mark Soloway, Donald Lamm, Raj Persad, Roger Buckley, Andreas Böhle, Marc Colombel & Joan Palou. (2014) Defining and Treating the Spectrum of Intermediate Risk Nonmuscle Invasive Bladder Cancer. Journal of Urology 192:2, pages 305-315.
Crossref
Crossref
Ok Målfrid Mangrud, Einar Gudlaugsson, Ivar Skaland, Ilker Tasdemir, Ingvild Dalen, Bianca van Diermen, Jan P.A. Baak & Emiel A.M. Janssen. (2014) Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder. Human Pathology 45:7, pages 1496-1503.
Crossref
Crossref
Lujia Wang, Chenchen Feng, Guanxiong Ding, Qiang Ding, Zhongwen Zhou, Haowen Jiang & Zhong Wu. (2013) Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer. Tumor Biology 35:4, pages 2989-2995.
Crossref
Crossref
Ok Målfrid Mangrud, Rune Waalen, Einar Gudlaugsson, Ingvild Dalen, Ilker Tasdemir, Emiel A. M. Janssen & Jan P. A. Baak. (2014) Reproducibility and Prognostic Value of WHO1973 and WHO2004 Grading Systems in TaT1 Urothelial Carcinoma of the Urinary Bladder. PLoS ONE 9:1, pages e83192.
Crossref
Crossref
Carlotta Sacerdote, Simonetta Guarrera, Fulvio Ricceri, Barbara Pardini, Silvia Polidoro, Alessandra Allione, Rossana Critelli, Alessia Russo, Angeline S. Andrew, Yuanqing Ye, Xifeng Wu, Lambertus A. Kiemeney, Andrea Bosio, Giovanni Casetta, Giuseppina Cucchiarale, Paolo Destefanis, Paolo Gontero, Luigi Rolle, Andrea Zitella, Dario Fontana, Paolo Vineis & Giuseppe Matullo. (2013)
Polymorphisms in the
XRCC1
gene modify survival of bladder cancer patients treated with chemotherapy
. International Journal of Cancer 133:8, pages 2004-2009.
Crossref
Crossref
Kristi L. Hoffman, Seth P. Lerner & Carolyn L. Smith. (2012) Raloxifene Inhibits Growth of RT4 Urothelial Carcinoma Cells via Estrogen Receptor-Dependent Induction of Apoptosis and Inhibition of Proliferation. Hormones and Cancer 4:1, pages 24-35.
Crossref
Crossref
Thorunn Rafnar, Sita H. Vermeulen, Patrick Sulem, Gudmar Thorleifsson, Katja K. Aben, J. Alfred Witjes, Anne J. Grotenhuis, Gerald W. Verhaegh, Christina A. Hulsbergen-van de Kaa, Soren Besenbacher, Daniel Gudbjartsson, Simon N. Stacey, Julius Gudmundsson, Hrefna Johannsdottir, Hjordis Bjarnason, Carlo Zanon, Hafdis Helgadottir, Jon Gunnlaugur Jonasson, Laufey Tryggvadottir, Eirikur Jonsson, Gudmundur Geirsson, Sigfus Nikulasson, Vigdis Petursdottir, D. Timothy Bishop, Sei Chung-Sak, Ananya Choudhury, Faye Elliott, Jennifer H. Barrett, Margaret A. Knowles, Petra J. de Verdier, Charlotta Ryk, Annika Lindblom, Peter Rudnai, Eugene Gurzau, Kvetoslava Koppova, Paolo Vineis, Silvia Polidoro, Simonetta Guarrera, Carlotta Sacerdote, Angeles Panadero, José I. Sanz-Velez, Manuel Sanchez, Gabriel Valdivia, Maria D. Garcia-Prats, Jan G. Hengstler, Silvia Selinski, Holger Gerullis, Daniel Ovsiannikov, Abdolaziz Khezri, Alireza Aminsharifi, Mahyar Malekzadeh, Leonard H. van den Berg, Roel A. Ophoff, Jan H. Veldink, Maurice P. Zeegers, Eliane Kellen, Jacopo Fostinelli, Daniele Andreoli, Cecilia Arici, Stefano Porru, Frank Buntinx, Abbas Ghaderi, Klaus Golka, José I. Mayordomo, Giuseppe Matullo, Rajiv Kumar, Gunnar Steineck, Anne E. Kiltie, Augustine Kong, Unnur Thorsteinsdottir, Kari Stefansson & Lambertus A. Kiemeney. (2011) European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Human Molecular Genetics 20:21, pages 4268-4281.
Crossref
Crossref
Charlotta Ryk, N. Peter Wiklund, Tommy Nyberg & Petra J. de Verdier. (2011) Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer. Nitric Oxide 25:3, pages 338-343.
Crossref
Crossref
Rama Devi MittalRuchika GangwarGinu P. GeorgeTulika MittalRakesh Kapoor. (2011) Investigative Role of Pre-MicroRNAs in Bladder Cancer Patients: A Case–Control Study in North India. DNA and Cell Biology 30:6, pages 401-406.
Crossref
Crossref
Per‐Uno Malmström. (2011) BLADDER TUMOURS: TIME FOR A PARADIGM SHIFT?. BJU International 107:10, pages 1543-1545.
Crossref
Crossref
Ruchika Gangwar, Anil Mandhani & Rama Devi Mittal. (2011) Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India. Surgery 149:1, pages 126-134.
Crossref
Crossref
Hubert John. 2011. Bladder Tumors:. Bladder Tumors:
365
376
.
Charlotta Ryk, Gunnar Steineck, N. Peter Wiklund, Tommy Nyberg & Petra J. de Verdier. (2010) The (CCTTT)n Microsatellite Polymorphism in the Nitric Oxide Synthase 2 Gene May Influence Bladder Cancer Pathogenesis. Journal of Urology 184:5, pages 2150-2157.
Crossref
Crossref
Dengfeng Cao, Robin T. Vollmer, Jason Luly, Samay Jain, Timur M. Roytman, Charles W. Ferris & M'Liss Ann Hudson. (2010) Comparison of 2004 and 1973 World Health Organization Grading Systems and Their Relationship to Pathologic Staging for Predicting Long-term Prognosis in Patients With Urothelial Carcinoma. Urology 76:3, pages 593-599.
Crossref
Crossref
Ruchika GangwarRama Devi Mittal. (2010) Association of Selected Variants in Genes Involved in Cell Cycle and Apoptosis with Bladder Cancer Risk in North Indian Population. DNA and Cell Biology 29:7, pages 349-356.
Crossref
Crossref
Vincent J. Low, Duolao Wang & Paul D. Abel. (2010) Survival of patients with bladder cancer from a UK hospital: a 10‐year follow‐up study. BJU International 105:12, pages 1667-1671.
Crossref
Crossref
Ruchika Gangwar, Anil Mandhani & Rama Devi Mittal. (2009) XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. Journal of Cancer Research and Clinical Oncology 136:5, pages 779-786.
Crossref
Crossref
Ruchika Gangwar, Dinesh Ahirwar, Anil Mandhani & Rama Devi Mittal. (2009) Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 680:1-2, pages 56-63.
Crossref
Crossref
Dinesh K. Ahirwar, Anil Mandhani, Anand Dharaskar, Pravin Kesarwani & Rama D. Mittal. (2009)
Association of tumour necrosis factor
‐
α gene (T‐1031C, C‐863A, and C‐857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette‐Guérin immunotherapy
. BJU International 104:6, pages 867-873.
Crossref
Crossref
Ruchika Gangwar, Anil Mandhani & Rama Devi Mittal. (2009) Caspase 9 and Caspase 8 Gene Polymorphisms and Susceptibility to Bladder Cancer in North Indian Population. Annals of Surgical Oncology 16:7, pages 2028-2034.
Crossref
Crossref
Sharon Sharir & Neil E. Fleshner. (2009) Lymph node assessment and lymphadenectomy in bladder cancer. Journal of Surgical Oncology 99:4, pages 225-231.
Crossref
Crossref
Ruchika Gangwar, Dinesh Ahirwar, Anil Mandhani & Rama Devi Mittal. (2009) Influence of XPD and APE1 DNA Repair Gene Polymorphism on Bladder Cancer Susceptibility in North India. Urology 73:3, pages 675-680.
Crossref
Crossref
David S. Morris, Alon Z. Weizer, Zaojun Ye, Rodney L. Dunn, James E. Montie & Brent K. Hollenbeck. (2009) Understanding bladder cancer death. Cancer 115:5, pages 1011-1020.
Crossref
Crossref
Chung-Hsin Chen, Hung-Yi Chiou, Yu-Mei Hsueh, Chien-Jen Chen, Hong-Jeng Yu & Yeong-Shiau Pu. (2009) Clinicopathological Characteristics and Survival Outcome of Arsenic Related Bladder Cancer in Taiwan. Journal of Urology 181:2, pages 547-553.
Crossref
Crossref
İpek Işık Gönül, Nalan Akyürek, Ayşe Dursun & Bora Küpeli. (2008) Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder. Pathology - Research and Practice 204:10, pages 707-717.
Crossref
Crossref
Dinesh Ahirwar, Pravin Kesarwani, Parmeet Kaur Manchanda, Anil Mandhani & Rama Devi Mittal. (2008) Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guérin immunotherapy in bladder cancer. Cancer Genetics and Cytogenetics 184:1, pages 1-8.
Crossref
Crossref
K.A. Guru, M.N. Jonsson & P. Wiklund. 2008. Robotic Urology. Robotic Urology
189
202
.
Ming LI, Tao SONG, Zhen-fei YIN & Yan-qun NA. (2007) XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer. Chinese Medical Journal 120:6, pages 469-473.
Crossref
Crossref
Francisco X Real & Núria Malats. (2007) Bladder cancer and apoptosis: matters of life and death. The Lancet Oncology 8:2, pages 91-92.
Crossref
Crossref
Charlotta Ryk, Rajiv Kumar, Somali Sanyal, Petra J. Berggren de Verdier, Kari Hemminki, Per Larsson, Gunnar Steineck & Sai-Mei Hou. (2006) Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours. Cancer Letters 241:1, pages 142-149.
Crossref
Crossref
Thomas Hofmann, Ruth Knüchel-Clarke, Arndt Hartmann, Robert Stöhr, Derya Tilki, Michael Seitz, Alexander Karl, Christian Stief & Dirk Zaak. (2006) Clinical Implications of the 2004 WHO Histological Classification on Non-Invasive Tumours of the Urinary Bladder. EAU-EBU Update Series 4:3, pages 83-95.
Crossref
Crossref
SHIGERU SAKANO, RAJIV KUMAR, PER LARSSON, ERIK ONELÖV, JAN ADOLFSSON, GUNNAR STEINECK & KARI HEMMINKI. (2005)
A single‐nucleotide polymorphism in the
XPG
gene, and tumour stage, grade, and clinical course in patients with nonmuscle‐invasive neoplasms of the urinary bladder
. BJU International 97:4, pages 847-851.
Crossref
Crossref
Willem Oosterlinck, Eduardo Solsona, Hideyuki Akaza, Christer Busch, Peter J. Goebell, Per-Uno Malmström, Haluk Özen & Paul Sved. (2005) Low-grade Ta (noninvasive) urothelial carcinoma of the bladder. Urology 66:6, pages 75-89.
Crossref
Crossref
Richard J. Sylvester, Adrian van der Meijden, J.A. Witjes, Gerhard Jakse, Norio Nonomura, Chris Cheng, Aaron Torres, Roger Watson & Karl Heinz Kurth. (2005) High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder. Urology 66:6, pages 90-107.
Crossref
Crossref
Karl T. Kelsey, Tomoko Hirao, Shuya Hirao, Tara Devi‐Ashok, Heather H. Nelson, Angeline Andrew, Joanne Colt, Dalsu Baris, J. Steven Morris, Alan Schned & Margaret Karagas. (2005) TP53 alterations and patterns of carcinogen exposure in a U.S. population‐based study of bladder cancer. International Journal of Cancer 117:3, pages 370-375.
Crossref
Crossref
Shuya Hirao, Tomoko Hirao, Carmen J. Marsit, Yoko Hirao, Alan Schned, Tara Devi‐Ashok, Heather H. Nelson, Angeline Andrew, Margaret R. Karagas & Karl T. Kelsey. (2005) Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer. Cancer 104:9, pages 1918-1923.
Crossref
Crossref
M. Seitz, D. Zaak, R. Knüchel-Clarke & C. Stief. (2005) HarnblasentumorenUrinary bladder tumours. Der Urologe 44:9, pages 1073-1086.
Crossref
Crossref
Anand L. Gidwani & Robin Brown. (2005) Where are the ‘poster boys’ for bladder cancer?. BJU International 95:9, pages 1368-1369.
Crossref
Crossref
Charlotta Ryk, Petra Berggren, Rajiv Kumar, Kari Hemminki, Per Larsson, Gunnar Steineck, Bo Lambert & Sai‐Mei Hou. (2004)
Influence of
GSTM1, GSTT1, GSTP1
and
NAT2
genotypes on the
p53
mutational spectrum in bladder tumours
. International Journal of Cancer 113:5, pages 761-768.
Crossref
Crossref
K T Kelsey, T Hirao, A Schned, S Hirao, T Devi-Ashok, H H Nelson, A Andrew & M R Karagas. (2004) A population-based study of immunohistochemical detection of p53 alteration in bladder cancer. British Journal of Cancer 90:8, pages 1572-1576.
Crossref
Crossref